Printer Friendly

Browse Tocilizumab topic

Articles

1-79 out of 79 article(s)
Title Author Type Date Words
Roche's Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone. Nov 11, 2019 1309
Auto-Injectors Market 2019 Trends, Share, Size, Growth Insight, Competitive Analysis, Statistics, Regional, And Global Forecast To 2022. Oct 31, 2019 1082
Auto-Injectors Market Global Size, Share, Growth prospect in the Future, Emerging Technologies, Gross Margin Analysis Till 2022. Oct 22, 2019 1056
Auto-Injectors Market 2019 Global Industry Profit Growth, Emerging Technologies, Competitive Landscape and Opportunity Assessment by Forecast 2022. Oct 8, 2019 951
FDA approves Roche's Rituxan (rituximab) in children with two rare blood vessel disorders. Sep 30, 2019 1207
Interleukin Inhibitors Market Size Is Expected To Reach USD 74.6 Billion By 2026 /Grand View Research Inc. Sep 20, 2019 690
Auto-Injectors Market Value 2019 Global Industry Analysis by Size, Share, Trend, Future Growth, Gross Margin, Revenue Till 2023. Sep 18, 2019 961
FDA grants Breakthrough Therapy Designation for Roche's Gazyva (obinutuzumab) in Lupus Nephritis. Sep 18, 2019 1218
Medicinal Products Containing The Active Substance Tocilizumab. Sep 18, 2019 128
Supply Of Medicinal Products Containing The Active Substance Tocilizumab. Sep 17, 2019 197
Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis. Bes, Cemal Disease/Disorder overview Sep 1, 2019 3427
Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab. Carrion-Barbera, Irene; Salman-Monte, Tarek Carlos; Castell, Sonia; Castro-Dominguez, Francisco; Oje Sep 1, 2019 2392
Booster vaccines: Largely safe in immunosuppressed kids. Bosworth, Ted Sep 1, 2019 514
The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease. Yan, Dong; Liu, JinJing; Zhang, Yuehua; Yuan, Wei; Xu, Yan; Shi, Jing; Li, Chaoran; Wang, Yining; Pe Sep 1, 2019 4720
Etiologic Spectrum and Follow-Up Results of Noninfectious Uveitis in Children: A Single Referral Center Experience. Cakan, Mustafa; Ekinci, Dilbade Yildiz; Karadag, Serife Gul; Ayaz, Nuray Aktay Sep 1, 2019 4249
Certolizumab Pegol Treatment in Three Patients With Takayasu Arteritis. Atas, Nuh; Varan, Ozkan; Babaoglu, Hakan; Satis, Hasan; Salman, Reyhan Bilici; Tufan, Abdurrahman Sep 1, 2019 3174
Australia : $56 million investment in Cancer and Inflammatory Disease medicines. Jul 31, 2019 731
Neuromyelitis optica spectrum disorder Market Insights, Trends, Share, and Outlook 2028. Jul 19, 2019 1468
United States : Kite Announces Plans to Bolster Industry-Leading Cell Therapy Manufacturing Capabilities With New Viral Vector Facility. Jul 17, 2019 824
Delivery Of The Drug Totsilizumab, Within The Framework Of The Implementation Of The Measures Of The Departmental Targeted Program prevention Of Disability Of The Population Of The Republic Of Karelia In 2019 (subprogram rheumatoid Arthritis ). Jul 17, 2019 131
Drug Preparations - 12 Lots: Lot No.1 - Tocilizumab; Lot No.2 - Infliximab; Lot No.3 - Famotidine; Lot # 4 - Octreotide; Lot # 5 - Iron, Parenteralpreparations; Lot # 6 - Valproicacid; Lot # 7 - Metamizolesodium; Lot # 8 - Diphenhydramine; Lot # 9 - Magne. Jul 5, 2019 127
Medicines - 4 Lots: Lot # 1 - Tocilizumab; Lot No.2 - Silicones; Lot No.3 - Mono; Lot # 4 - Thioctic Acid. Jul 5, 2019 101
Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report. Fujita, Yuya; Nawata, Masao; Nagayasu, Atsushi; Someya, Kazuki; Saito, Kazuyoshi; Tanaka, Yoshiya Jul 1, 2019 2909
Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies. Chang, Che-Mai; Hsu, Yu-Wen; Wong, Henry Sung-Ching; Wei, James Cheng-Chung; Liu, Xiao; Liao, Hsien- Jul 1, 2019 6238
Delivery Of Medicinal Products Used In Drug Programs By Packet (poland-katowice: Pharmaceutical Products). Jun 20, 2019 107
Gilead Sciences (NASDAQ: GILD) - Kite Announces New Yescarta[R] Data From ZUMA-1 -- 3/6/2019. Jun 13, 2019 2022
United States : Kite Announces End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia. Jun 7, 2019 661
Kite Releases End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia. Jun 4, 2019 625
Kite announces new Yescarta data from ZUMA-1. Jun 3, 2019 577
Bellicum presents interim data for BPX-601 in Metastatic Pancreatic Cancer. Jun 2, 2019 456
Kite announces end of Phase 1 ZUMA-3 results for KTE-X19. Jun 2, 2019 340
Accelerated Nodulosis in a Patient With Rheumatoid Arthritis. Enginar, Ayse Unal; Nur, Hakan; Gilgil, Erdal; Kacar, Cahit Jun 1, 2019 1922
Canada : B.C. expands use of biosimilars to offer coverage for more treatment options. May 30, 2019 798
Chugai Pharmaceutical Co., Ltd. - Chugai's Actemra Intravenous Infusion Receives Additional Approval for Adult Still's Disease -- 22/5/2019. May 28, 2019 717
'I could barely walk and nearly lost my sight - then a drugs trial saved my life' REAL LIFE; When Carol Howell was diagnosed with a debilitating condition, she was willing to take a risk to get her health back. May 5, 2019 1482
'I could barely walk and nearly lost my sight -- then a drug trial saved my life'; When Carol Howell was diagnosed with a debilitating condition, she was willing to take a risk to get her health back... May 5, 2019 1647
Treatment goals for children with localized scleroderma. Jancin, Bruce May 1, 2019 1220
Gilead Sciences (NASDAQ: GILD) - Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities -- 24/4/2019. Apr 25, 2019 1317
Survey on transportation and storage of biological therapies by patients. Saavedra, Maira Arias; Aimo, Carolina; Andrade, Jose Astudillo; Alvarez, Damaris; Sequeira, Gabriel; Report Apr 23, 2019 4272
Disseminated hollow and solid lung nodules as a unique pulmonary manifestation of rheumatoid arthritis. Jungraithmayr, Wolfgang; Enz, Njanja; Lippek, Frank Clinical report Apr 23, 2019 565
Autolus reports initial results from ALLCAR19 Phase 1/2 trial. Apr 1, 2019 251
Switzerland : European Commission approves Roches MabThera (rituximab) for a rare autoimmune disease. Mar 18, 2019 889
Supply Of Medicines Whose Active Principle Is Tocilizumab For The Hospitals Of The Zamora Healthcare Complex, Belonging To The Health Care Management Of Zamora. Mar 9, 2019 131
Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy. Cerda, Osvaldo Luis; Correa, Maria De Los Angeles; Granel, Amelia; Marcos, Ana Ines; Giraldo, Claudi Report Mar 1, 2019 3475
Algorithm addresses TNF inhibitor-induced psoriasis. Craven, Jeff Drug overview Feb 1, 2019 744
Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF. Yilmaz, Sedat; Tekgoz, Emre; Cinar, Muhammet Dec 1, 2018 2194
Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis. Choi, In Ah; Lee, Sang Jin; Park, Won; Park, Sung Hwan; Shim, Seung-cheol; Baek, Han Joo; Yoo, Dae-H Dec 1, 2018 3193
Combo Therapy Not Needed If Low RA Disease Activity Achieved; Dropping methotrexate, continuing tocilizumab does not lead to worsening of disease activity. Sep 26, 2018 261
Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab. Jacobs, Ben; Jawad, Ali; Fattah, Zozik Sep 1, 2018 1709
Comparacion de citocinas plasmaticas antes y despues del tratamiento con rituximab en pacientes con artritis reumatoide y lupus eritematoso sistemico asociado a poliautoinmunidad. Barahona Correa, Julian Esteban; Franco Cortes, Manuel Antonio; Uribe, Juana Angel; Rodriguez Camach Jul 1, 2018 8029
OUTCOME OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS. Balameena, S.; Ravichandran, R. Report Jun 4, 2018 1612
Passive Smoking is Responsible for Disease Activity in Female Patients With Rheumatoid Arthritis. Kim, Seong Kyu; Choe, Jung Yoon Jun 1, 2018 4076
Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection. Einecke, Gunilla; Brasen, Jan Hinrich; Hanke, Nils; Haller, Hermann; Schwarz, Anke Disease/Disorder overview Jan 1, 2018 4179
Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. Turck, Natacha; Eperon, Simone; Gracia, Maria De Los Angeles; Oberic, Aurelie; Hamedani, Mehrad Jan 1, 2018 7276
Rituximab Induced Pulmonary Edema Managed with Extracorporeal Life Support. Miller, Jacob R.; Isakow, Warren; Masood, Muhammad F.; Aguilar, Patrick; Sanfilippo, Kristen M.; Bal Jan 1, 2018 2452
Myokines as Possible Therapeutic Targets in Cancer Cachexia. Manole, Emilia; Ceafalan, Laura C.; Popescu, Bogdan O.; Dumitru, Carmen; Bastian, Alexandra E. Jan 1, 2018 6715
Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies. Sun, Shangjun; Hao, He; Yang, Ge; Zhang, Yi; Fu, Yang Jan 1, 2018 7613
Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome. Shamriz, Oded; Tal, Yuval; Gross, Menachem Jan 1, 2018 5574
Immune System and Chronic Diseases 2018. Bagatini, Margarete Dulce; Cardoso, Andreia Machado; Reschke, Cristina Ruedell; Carvalho, Fabiano Ba Jan 1, 2018 1369
NRF2 Activation Inhibits Both TGF-[beta]1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment. Mitamura, Yasutaka; Murai, Mika; Mitoma, Chikage; Furue, Masutaka Jan 1, 2018 5628
A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge. Hashmi, Hamza; Murray, Drew; Greenwell, John; Shaikh, Marwan; Basu, Soumit; Krem, Maxwell Jan 1, 2018 3240
Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis. Figueiredo-Braga, Margarida; Cornaby, Caleb; Cortez, Alice; Bernardes, Miguel; Terroso, Georgina; Fi Jan 1, 2018 7386
Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results. Navarini, Luca; Bisogno, Tiziana; Margiotta, Domenico Paolo Emanuele; Piccoli, Alessandra; Angeletti Jan 1, 2018 3764
Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis. O'Dwyer, Ronan; Kovaleva, Marina; Zhang, Jiquan; Steven, John; Cummins, Emma; Luxenberg, Deborah; Da Jan 1, 2018 7681
Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis. Xu, Nuo; Cui, Yi; Xie, Tianlu; Zheng, Mi Clinical report Jan 1, 2018 7131
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency. Rafiq, Nadia K.; Lachmann, Helen; Joensen, Frodi; Herlin, Troels; Brogan, Paul A. Jan 1, 2018 3551
Endobronchial Watanabe Spigots for Treatment of Pyopneumothorax due to Nontuberculous Mycobacteriosis in a Patient with Rheumatoid Arthritis: A Case Report Based on Past Experience. Kawai, Norikazu; Kawaguchi, Takeshi; Tojo, Takashi; Osa, Takao; Yamamoto, Yoshifumi; Yasukawa, Motoa Jan 1, 2018 1664
Efficacy of Cyclosporine in the Induction and Maintenance of Remission in a Systemic Lupus Erythematosus Patient Presenting with Macrophage-Activating Syndrome. Cruz-Perez, Franchesca; Vila, Salvador; Rios, Grissel; Vila, Luis M. Jan 1, 2018 2829
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment. Filippini, M.; Cartella, S.; Bonzanini, O.; Morello, E.; Tincani, A. Jan 1, 2018 1881
Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review. Ikeuchi, Hidekazu; Koinuma, Kana; Nakasatomi, Masao; Sakairi, Toru; Kaneko, Yoriaki; Maeshima, Akito Jan 1, 2018 3132
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment. Cacciapaglia, Fabio; Anelli, Maria Grazia; Rinaldi, Angela; Fornaro, Marco; Lopalco, Giuseppe; Scios Jan 1, 2018 5416
AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis. Bird, Paul; Peterfy, Charles; Countryman, Peter; Griffiths, Hedley; Barrett, Rina; Youssef, Peter; J Clinical report Jan 1, 2018 6219
High Disease Activity May Increase Fear-Avoidance Beliefs in Rheumatoid Arthritis. Tezcan, Mehmet Engin; Dogan, Berfu Cinkit; Sen, Nesrin; Sargin, Mehmet Report Dec 1, 2017 7474
Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab. Miao, Shiwei; Fan, Li; Zhao, Liang; Ding, Ding; Liu, Xiaohui; Wang, Haibin; Tan, Wen-Song Report Jan 1, 2017 7644
Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy. van Duin, David; Miranda, Cyndee; Husni, Elaine Case study Apr 1, 2011 1350
Genentech gets FDA clearance for rheumatoid arthritis drug. Feb 15, 2010 482
Roche Holding AG's experimental rheumatoid arthritis drug Actemra significantly inhibited joint damage progression, according to one-year data from a two-year late stage clinical trial, the Swiss drugmaker said. Brief article Nov 3, 2008 199
Tocilizumab superior to methotrexate for RA. Walsh, Nancy Clinical report Sep 15, 2008 568
Refractory RA appears to respond to Tocilizumab. Walsh, Nancy Clinical report Sep 15, 2008 560

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters